- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04081727
Zip-Stitch™ for Vaginal Cuff Closure in Laparoscopic Hysterectomy - Safety & Efficacy Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Wynnewood, Pennsylvania, United States, 19096
- Lankenau Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
1. Provision of signed and dated Informed Consent Form 2. Stated willingness to comply with all study procedures, including participation in follow-up visits and telephonic follow-up 3. Female 18 years and older 5. Indicated for Laparoscopic Hysterectomy (may include TLH, LAVH, robotic assisted vaginal hysterectomy)
Exclusion Criteria:
- History of HIV
- History of Hepatitis C
- History of diabetes, that in the opinion of the investigator may delay healing
- Current use of systemic corticosteroids
- Active infection of genitals, vagina, cervix, uterus or urinary tract
- Active bacteremia, sepsis or other active systemic infection
- Presence of Sexually Transmitted Infection (STI)
- Evidence of pelvic inflammatory disease (PID)
- Known clotting defects or bleeding disorders
- Hemoglobin < 8 g/dL
- Metastatic disease
- On anticoagulant therapy
- Participation in another interventional trial
- Pregnancy
- Abnormal PAP results that have not been fully evaluated, or in the opinion of the investigator may indicate abnormal vaginal cuff healing
- Co-morbidities that, in the opinion of the investigator, may indicate risk of abnormal vaginal cuff healing
- Intra-op: Bowel injury during laparoscopic hysterectomy procedure prior to attempted cuff closure
16. Intra-op: Bladder injury during laparoscopic hysterectomy procedure prior to attempted cuff closure 17. Intra-op: Cases in which surgeon cannot identify adequate tissue along the cuff to apply suture laparoscopically 18. Intra-op: Cases requiring conversion to laparotomy prior to study intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Test Article - Zip-stitch Clips
Zip-stitch clips for vaginal cuff closure during laparoscopic hysterectomy
|
The assigned intervention is used to close the cuff following colpotomy.
|
Other: Reference Group - V-Loc Barbed Suture
Will not be comparative against the test article, but will be performed for reference and safety.
|
The assigned intervention is used to close the cuff following colpotomy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Primary Efficacy Endpoint - Number of Participants With Implant Passing
Time Frame: Six-weeks post-operative
|
Frequency of implant passing following laparoscopic vaginal cuff closure within six weeks
|
Six-weeks post-operative
|
Primary Safety Endpoint - Number of Participants With Vaginal Cuff Dehiscence
Time Frame: Six-weeks post-operative
|
Frequency of Vaginal Cuff Dehiscence following laparoscopic vaginal cuff closure.
|
Six-weeks post-operative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With Successful Vaginal Cuff Closure
Time Frame: Performed at one week, six weeks, and six months after surgery; reported here at six weeks
|
Binary, visual surgeon cuff closure evaluation
|
Performed at one week, six weeks, and six months after surgery; reported here at six weeks
|
Number of Participants With Vaginal Cuff Healing
Time Frame: Performed at one week, six weeks, and six months after surgery; reported here at six weeks
|
Binary, visual surgeon cuff healing evaluation
|
Performed at one week, six weeks, and six months after surgery; reported here at six weeks
|
Comparison of Number of Participants With Implant Passing - Test to Reference
Time Frame: evaluated at six months post-operative
|
Percentage of subjects experiencing implant passing will be compared between test and reference groups
|
evaluated at six months post-operative
|
Percentage of Participants With Implant Passing Events Determined to Impact Patient Safety
Time Frame: Evaluated after one week, six week, six month, and twelve month follow-up
|
Each reported implant passing event will be evaluated for association with adverse events.
Compared as a percentage of patients in the test vs. reference groups.
|
Evaluated after one week, six week, six month, and twelve month follow-up
|
Comparison of Incidence of Adverse Events - Test to Reference
Time Frame: Evaluated after one week, six week, six month, and twelve month follow-up; reported here for all time
|
Adverse events and serious adverse events will be tabulated for both the test and reference groups.
|
Evaluated after one week, six week, six month, and twelve month follow-up; reported here for all time
|
Number of Participants With Non-increase in Dyspareunia at Follow-up
Time Frame: Six-months post-operative and again at 12 months post-operative
|
Non-increase in reported individual subject dyspareunia from baseline to follow-up will be compared (test versus reference group) using the relevant sexual discomfort module of the Female Sexual Function Index (FSFI).
The FSFI is a validated metric of female sexual function, where lower scores indicate poor sexual function.
Non-increase in sexual discomfort will be compared between test and control groups.
|
Six-months post-operative and again at 12 months post-operative
|
Number of Participants With Non-increase in Pain at Follow-up
Time Frame: Six-months post-operative and again at 12 months post-operative; count is number of subjects with non-increase
|
Non-increase in reported individual subject pain from baseline to follow-up will be compared (test versus reference group) using an 11-point Numerical Rating Scale, where 0 indicates no pain, and 10 indicates maximum possible pain.
|
Six-months post-operative and again at 12 months post-operative; count is number of subjects with non-increase
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: David O Holtz, M.D., Main Line Health
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- QD-PRO-045 Rev002
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Laparoscopic Hysterectomy
-
University of North Carolina, Chapel HillCompletedLaparoscopic HysterectomyUnited States
-
University of North Carolina, Chapel HillCompletedLaparoscopic Hysterectomy and/or Laparoscopic SacrocolpopexyUnited States
-
Balikesir UniversityCompleted
-
Ain Shams UniversityCompleted
-
Samyang Biopharmaceuticals CorporationRecruitingLaparoscopic HysterectomyKorea, Republic of
-
ZSX Medical LLCEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingLaparoscopic HysterectomyUnited States
-
Danbury HospitalEthicon, Inc.Completed
-
Mansoura UniversityRecruitingTotal Laparoscopic HysterectomyEgypt
-
Ilsan Cha hospitalRecruitingTotal Laparoscopic HysterectomyKorea, Republic of
-
ZSX Medical LLCCompletedTotal Laparoscopic HysterectomyMexico
Clinical Trials on Zip-stitch(TM)
-
ZSX Medical LLCCompletedTotal Laparoscopic HysterectomyMexico
-
ZSX Medical LLCEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingLaparoscopic HysterectomyUnited States
-
ZipLine Medical Inc.WithdrawnArthroplasty, Replacement, KneeUnited States
-
Sohag UniversityCompletedCosmotic Outcome of Distal Penile Hypospidias Repair Using Stitch by Stitch Glanuloplasty Versus TIPDistal Penile HypospadiasEgypt
-
Aesculap AGB.Braun Surgical SAActive, not recruitingInjury of Abdominal WallAustria, Germany
-
ZipLine Medical Inc.UnknownC.Surgical Procedure; Dehiscence, Cesarean SectionIsrael
-
ZipLine Medical Inc.CompletedWound Healing | Arthroplasty, Knee ReplacementUnited States
-
Martini-Klinik am UKE GmbHCompletedLymphocele After Surgical ProcedureGermany
-
Texas Tech University Health Sciences Center, El...CompletedPatient Satisfaction | Complications | Operative Time | Postoperative BleedingUnited States
-
Hospital del MarCompleted